Studio LUNA - WALCE - Women Against Lung Cancer in Europe

<img alt="logotype" style="height: 55px;" data-src="https://www.awavesdev.it/wp-content/uploads/2020/09/no-bg.png" class="default_logo lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="default_logo" src="https://www.awavesdev.it/wp-content/uploads/2020/09/no-bg.png" alt="logotype" style="height: 55px;">

Contatti

Regione Gonzole, 10
10043 Orbassano (TO)

info@womenagainstlungcancer.eu

+39 0119026980

Studio LUNA

Studio multicentrico, con tre gruppi di trattamento, per valutare l’efficacia e la sicurezza di pasireotide LAR o everolimus in monoterapia o in combinazione in pazienti con carcinoma neuroendocrino ben differenziato del polmone e del timo

Studio LUNA (pdf 420kb)

Multicenter 3-arm trial to evaluate the efficacy and safety of Pasireotide LAR or Everolimus alone or in combination in patients with well differentiated neuroendocrine carcinoma of the lung and thymus

LUNA Trial (pdf 1,31Megab)Multicenter 3-arm trial to evaluate the efficacy and safety of Pasireotide LAR or Everolimus alone or in combination in patients with well differentiated neuroendocrine carcinoma of the lung and thymus

LUNA Trial (pdf 1,31Megab)

13